External Defibrillators Market Projected to Reach $5.2 Billion by 2031: A Detailed Analysis by Allied Market Research Reveals a Noteworthy 7.0% CAGR Surge

Allied Market Research has recently released an extensive report titled “External Defibrillators Market by Product Type and End User: Global Opportunity Analysis and Industry Forecast, 2021-2031.” This report provides a detailed examination of the dynamic landscape of the global external defibrillators industry, projecting significant growth from $2.7 billion in 2021 to an estimated $5.2 billion by 2031, with a notable Compound Annual Growth Rate (CAGR) of 7.0% over the forecast period.

𝐄𝐱𝐭𝐞𝐫𝐧𝐚𝐥 𝐃𝐞𝐟𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2109

Key Highlights:

Driving Forces, Challenges, and Opportunities:

The growth of the market is propelled by a surge in the development of public access defibrillators (PAD) by both public and private organizations, an increase in the number of key players innovating advanced defibrillator devices, and a rising incidence of cardiac diseases. Despite pricing pressures posing challenges, opportunities arise with the adoption of technologically advanced defibrillator devices, growing demand for quality medical care, and an increasing prevalence of sudden cardiac arrest (SCA).

Covid-19 Impact and Market Resilience:

The Covid-19 pandemic posed challenges to the external defibrillators market, leading to a reduction in the demand for public access defibrillators (PAD) due to widespread lockdowns. Manufacturing activities faced hindrances, including shortages of raw materials, disrupted supply chains, and a scarcity of workforce. However, the market is expected to rebound as restrictions ease, underscoring the resilience of the external defibrillators sector.

𝐄𝐱𝐭𝐞𝐫𝐧𝐚𝐥 𝐃𝐞𝐟𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/2109

Segmental Analysis: AEDs Leading the Charge:

The automated external defibrillator (AED) segment emerged as the frontrunner in 2021, contributing to over two-thirds of the global market. It is poised to maintain its dominance throughout the forecast period, fueled by initiatives from major companies, increased adoption of defibrillators in healthcare facilities, and the implementation of public access defibrillation programs. The wearable cardioverter defibrillator (WCD) segment is projected to exhibit the highest CAGR of 12.9% from 2022 to 2031, driven by the growing prevalence of cardiovascular disorders, an aging population, and the user-friendly nature of non-invasive devices.

End User Dynamics: Hospitals Maintain Dominance:

Hospitals dominated the market in 2021, accounting for over half of the global external defibrillators market revenue. This trend is expected to continue, fueled by the increasing volume of patients, strategies adopted by key manufacturers, and the growing adoption of various external defibrillator types by hospitals. The alternate care segment is forecasted to register the fastest CAGR of 8.7% from 2022 to 2031, driven by the rising installation of defibrillators in public places.

Regional Outlook: North America Leads, Asia-Pacific on the Rise:

North America secured the largest market share in 2021, holding more than two-fifths of the global market. This dominance is attributed to an increased number of defibrillator installations in hospitals and public places. However, Asia-Pacific is expected to exhibit the largest CAGR of 8.9% during the forecast period, fueled by a rising incidence of cardiovascular diseases, increased healthcare costs, and improvements in healthcare infrastructure.

Key Market Players:

Leading companies shaping the external defibrillators market include Nihon Kohden Corporation, Asahi Kasei Corporation, Koninklijke Philips N.V., CU Medical Germany GMBH, Mediana Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Stryker, General Electric Company, Schiller AG, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

𝐇𝐚𝐯𝐞 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬? 𝐂𝐨𝐧𝐬𝐮𝐥𝐭 𝐰𝐢𝐭𝐡 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/connect-to-analyst/2109